Single-system Langerhans Cell Histiocytosis with Skin Ulcers as the Initial Presentation

Xue-min Wang,Ye-qiang Liu,Bin Li,Ming Li,Yan Peng,Wen-cheng Jiang

DOI: https://doi.org/10.2340/actadv.v104.40193

2024-08-05

Abstract:Abstract is missing (Short communication)

dermatology

What problem does this paper attempt to address?

Small Cell Lung Cancer Presenting As Dermatomyositis: Mistaken for Single Connective Tissue Disease

Guanqun Chao,Lizheng Fang,Chongrong Lu,Zhouwen Chen

DOI: https://doi.org/10.1007/s00296-011-1857-3

2011-01-01

Rheumatology International

Abstract:Dermatomyositis (DM) is well-known to be associated with several types of malignancy. This case emphasizes the importance of a thorough examination for an underlying cancer, in patients with the symptoms of dermatomyositis. We report the case of a 62-year-old Chinese man who presented with a two-month history of edema of face and neck, together with erythema of the eyelids diagnosed of small cell lung cancer. Initially, it was thought to be single connective tissue disease such as DM. This study highlights the importance of a thorough physical examination when visiting a patient.
Huriez Syndrome with Squamous Cell Carcinoma

Xiao-Yong MAN,Wei LI,Jia-Qi CHEN,Jiong ZHOU,Yuan-Jin LIAO,Chun-Ming LI,Sui-Qing CAI,Min ZHENG

DOI: https://doi.org/10.1684/ejd.2011.1259

2011-01-01

European Journal of Dermatology

Abstract:ejd.2011.1259 Auteur(s) : Xiao-Yong MAN, Wei LI, Jia-Qi CHEN, Jiong ZHOU, Yuan-Jin LIAO, Chun-Ming LI, Sui-Qing CAI, Min ZHENG minz@zju.edu.cn Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, 88 Jiefang Rd, Hangzhou, 310009 China A 26-year-old male with an undiagnosed chronic scleroatrophic disorder and hypohidrosis involving his hands since infancy, presented with a rapidly growing painful tumor on his right thumb, which started out as an erythematous [...]
Skin Picking in Atopic Dermatitis and Psoriasis Patients: A Single-centre Cross-sectional Study in China

Yanjiao Ju,Mufeng Li,Xueyan Lu,Cheng Zhao,Chunlei Zhang,Zhiqiang Xie

DOI: https://doi.org/10.2340/actadv.v101.908

2022-01-01

Abstract:Abstract is missing (Short communication)
Cutaneous Langerhans Cell Histiocytosis in an Old Man:A Case Report

Jing He

2001-01-01

Abstract:Langerhans cells histiocytosis(LCH) is a disease characterized by collections of Langerhans cells, and these cells accumulate in various tissues and cause damage. LCH is most frequent in children, seldomly seen in adults and extremely rare in the elderly. A 62 year old man presented with erythroderma with marked pruritus. He was diagnosed as LCH examined by clinic, pathology and immunohistiochemistry of biopsy both in lymph node and skin. The patient got a satisfactory therapeutic effect after an appropriate treatment.
A rare imaging presentation with multisystemic clinicopathological features of Langerhans cell histiocytosis: Case report and literature review

Xiaofen Li,Yulu Wang,Qian Liu,Qingyun Zeng,Huan Fu,Jianlin He,Ingo G H Schmidt-Wolf,Amit Sharma,Fengxiang Liao

DOI: https://doi.org/10.1097/MD.0000000000034881

2023-09-01

Abstract:Rationale: Langerhans cell histiocytosis (LCH) is a kind of rare disease in which dendritic cells proliferate abnormally. It often occurs in children and can involve any tissue and organ. The affected sites usually include bone, skin, pituitary gland, and lungs, while the thyroid gland and external auditory canal are rarely observed. The perineal and labial involvement of this disease has not been reported yet. Patient concerns: A 47-year-old female patient experienced a swelling of the anterior neck area without an obvious inducement. She noticed a quail egg-like mass on the left side, and the mass increased progressively within 3 months. The anterior neck area was found to be swollen, and some flaky red rashes were seen on the scalp and bilateral external auditory canals. Diagnoses: Imaging examination showed enlarged thyroid and cervical lymph nodes, multiple low-density nodules in the liver, and reduced signal in the posterior pituitary gland. The biopsy pathological result of the increased left cervical lymph node indicated that LCH was detected. Interventions: VP regimen (vincristine, dexamethasone per os) and related supportive treatments were given as inducing chemotherapy for 6 weeks. Outcomes: After the second chemotherapy, the rash on the scalp and external auditory canal improved, and the neck mass was significantly reduced. After the third chemotherapy, the rash was mostly disappeared, while the neck lumps increased during chemotherapy. Thus, clatribine chemotherapy was recommended as the follow-up. Lessons: Imaging examinations played an important role in the diagnosis and follow-up of the disease, especially 18F-FDG PET/CT, which could show multiple involving organs at the same time. When a patient suffering from diabetes insipidus, skin rash, or fever, has a high FDG uptake PET/CT result in multiple tissues and organs throughout the body, it is necessary to consider the possibility of LCH.
Adult Presentation of Cutaneous Langerhans Cell Histiocytosis

Elizabeth Robinson,Ayah Nawwar,Julie Searle,Iain Lyburn

DOI: https://doi.org/10.1097/rlu.0000000000005109

IF: 10.6

2024-02-08

Clinical Nuclear Medicine

Abstract:Abstract Langerhans cell histiocytosis (LCH) is a rare hematological disease, more common in pediatric populations. A 26-year-old man with biopsy-proven cutaneous LCH underwent 18 F-FDG PET/CT systemic staging. 18 F-FDG PET/CT highlighted multiple sites of avid cutaneous disease within the natal cleft. Additional characteristic cystic lung disease was seen on the CT component and focal uptake in the pituitary stalk/hypothalamic region noted, a common but occult site of disease in this patient. Because of the rarity of adult-onset cutaneous LCH, guidance on management and staging is lacking. 18 F-FDG PET/CT is critical to baseline evaluation of systemic disease, as illustrated here.

radiology, nuclear medicine & medical imaging
A case report of multicentric reticulohistiocytosis with atypical cutaneous presentation

Xiangru Chen,Lin An,Zhongmin Jiang,Yuxi Jia

DOI: https://doi.org/10.3389/fimmu.2024.1344313

IF: 7.3

2024-02-14

Frontiers in Immunology

Abstract:Multicentric reticulohistiocytosis (MRH) is a rare systemic disorder characterized by histiocytic hyperplasia that mainly involves the skin, mucous membranes, and joints. The typical clinical features include papules, nodules, and arthritis. MRH lesions are relatively extensive but small and scattered. Joint inflammation is characterized by diffuse symmetric polyarthritis as the first symptom, which can be severe and disabling due to destructive joint changes. MRH is easily misdiagnosed in clinical practice. Here, we report the case of an elderly male patient who presented with polyarticular pain in the hip and interphalangeal joints as the first manifestation, followed by the development of large, isolated, bulging skin nodules, which are atypical MRH lesions. This is rare in all MRH case reports, and we made the correct diagnosis by combining skin histopathology, immunohistochemistry, and other clinical examinations. We performed surgical treatment on the local skin lesions of this patient. This case suggests that clinicians should actively correlate the condition and accurately diagnose MRH when encountering atypical skin changes or other diseases as the first symptom and explore the mechanisms of MRH and other clinical manifestations.

immunology
Clinical characteristics, genomic profiling and outcomes of single system multifocal Langerhans cell histiocytosis in adults with bone involvement

Hong-xiao Han,Long Chang,Min Lang,He Lin,Jian Li,Ming-hui Duan,Dao-bin Zhou,Xin-xin Cao

DOI: https://doi.org/10.1038/s41408-023-00913-8

IF: 9.812

2023-09-06

Blood Cancer Journal

Abstract:Blood Cancer Journal, Published online: 05 September 2023; doi:10.1038/s41408-023-00913-8 Clinical characteristics, genomic profiling and outcomes of single system multifocal Langerhans cell histiocytosis in adults with bone involvement

oncology,hematology
Primary cutaneous aggressive epidermotropie CD8-positive cytotoxic T-cell lymphoma:a case report

Yang WANG,Lin NONG,Ling-shen WU,Ting LI,Ping TU

DOI: https://doi.org/10.3760/cma.j.issn.0412-4030.2009.04.006

2009-01-01

Chinese Journal of Dermatology

Abstract:A 19-year-old Chinese woman presented with progressive ulcers and recurrent fever for 1 year.The lesions originally began with purplish red maculopapules,then rapidly developed into ulcer with severe pain and spread to the trunk and extremities accompanied by intermittent fever.Histopathology revealed lymphoid infiltration of middle and large atypical T cells throughout the dermis and subcutaneous fat laver along with focal epidermotropism.The lymphoid infiltrates were positive for CD3,CD8,T-cell intercellular antigen(TLA)and T-cell receptor β(TCR-β).Gene analysis showed the rearrangement of T-cell receptor gene.According to the above findings,the patient was diagnosed as primary cutaneous aggressive epidermotropic CD8-positive cytotoxic T-cell lymphoma. Combined thempy with cyclophosphamide,vincristine,prednisone and bleomycin resulted in partial remission of skin lesions,but she eventually died 22 months after the onset of disease.
Single-cell analyses reveal novel molecular signatures and pathogenesis in cutaneous T cell lymphoma

Xiaotong Xue,Zhenzhen Wang,Zihao Mi,Tingting Liu,Chuan Wang,Peidian Shi,Lele Sun,Yongliang Yang,Wenchao Li,Zhe Wang,Hong Liu,Furen Zhang

DOI: https://doi.org/10.1038/s41419-022-05323-5

2022-11-19

Pathogenesis

Abstract:Abstract Sézary syndrome (SS) is a rare and aggressive type of cutaneous T cell lymphoma (CTCL) with a poor prognosis. Intra-tumoral heterogeneity caused by different disease compartments (e.g., skin, blood) and poor understanding of the pathogenesis has created obstacles to the precise diagnosis and targeted treatment of the disease. Here we performed a comprehensive analysis by integrating single-cell transcriptomic data of 40,333 peripheral blood mononuclear cells (PBMCs) and 41,580 skin cells, as well as single-cell chromatin accessibility data of 11,058 PBMCs from an SS patient and matched healthy controls (HCs). Validation and functional investigation were carried out in an independent cohort consisting of SS patients, mycosis fungoides (MF) patients, psoriatic erythroderma patients, and HCs, as well as multiple cell lines. The analysis revealed that skin-derived Sézary cells (SCs) had a shifting trend to more advanced mature phenotypes compared to blood-derived SCs. A series of specific marker genes ( TOX , DNM3 , KLHL42 , PGM2L1 , and SESN3 ) shared in blood- and skin-derived SCs were identified, facilitating the diagnosis and prognosis of MF/SS. Moreover, luciferase reporter assays and gene knockdown assays were used to verify that KLHL42 was transcriptionally activated by GATA3 in SS. Functional assays indicated that KLHL42 silencing significantly inhibited aggressive CTCL cell proliferation and promoted its apoptosis. Therefore, targeting inhibition KLHL42 might serve as a promising therapeutic approach in CTCL.
Chronic lymphocytic leukemia/small lymphocytic lymphoma complicated with skin Langerhans cell sarcoma: A case report

Shao-Yan Li,Yan Wang,Li-Hua Wang

DOI: https://doi.org/10.12998/wjcc.v9.i34.10715

2021-12-06

World Journal of Clinical Cases

Abstract:BACKGROUND: Langerhans cell sarcoma (LCS) is a rare malignancy with poor prognosis. LCS and chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) can occur in the same diseased tissues, such as lymph nodes or skin.CASE SUMMARY: A 48-year-old female Han Chinese patient was admitted for generalized lymph node enlargement for 6 years and abdominal distension for 1 wk. She was diagnosed with small B-cell lymphoma (stage IV)/CLL (Benet stage B) and received chemotherapy. She started oral ibrutinib in February 2019. She was hospitalized on June 11, 2019, and a 1.5 cm × 1.5 cm dark-red nodule with ulceration scalp lesion was found. Biopsy revealed LCS but without CLL/SLL. She was diagnosed with CLL/SLL (Binet stage C, Rai stage IV) accompanied by secondary histiocytic sarcomas and skin LCS and received cyclophosphamide, doxorubicin, vincristine, dexamethasone, and etoposide but developed severe cytopenia. She ultimately refused treatments and discharged spontaneously. She died on September 12, 2019. The literature review showed that in patients with CLL/SLL, skin lesions of LCS are accompanied by CLL/SLL. This patient was different from the previously reported cases of skin LCS in patients with CLL/SLL.CONCLUSION: In this patient, the skin lesion of LCS showed no concomitant CLL/SLL.

medicine, general & internal
Adult Langerhans cell histiocytosis with multi‑system bone, skin, lung and liver involvement: A case report

Qiucheng Lei,Xitao Hong,Jianxiang Yuan,Huazhen Zheng,Feiwen Deng

DOI: https://doi.org/10.3892/br.2024.1850

2024-09-02

Abstract:Langerhans cell histiocytosis (LCH) is a rare neoplastic disorder marked by the uncontrolled proliferation and accumulation of immature myeloid dendritic cells, which originate from the bone marrow. Although LCH can involve various organs, including bone, lymph nodes and skin, multi-system bone, liver and lung involvement with LCH is rare in adults. A case of a 49-year-old man diagnosed with multi-system, aggressive LCH involving bone, skin, lung and liver is presented in the present study. The initial radio-clinic presentation of the patient was initially suggestive of a bone tumor. The current case report aims to draw attention to this rare disease and discuss the diagnostic approach and therapeutic management, which should be noted to help physicians more rapidly identify, diagnose and treat comparable cases.
Langerhans Cell Histiocytosis: A Population-based Study of Anatomical Distribution and Treatment Patterns

Xianglin Hu,Ilia N. Buhtoiarov,Chunmeng Wang,Zhengwang Sun,Qinyuan Zhu,Wending Huang,Wangjun Yan,Yangbai Sun

DOI: https://doi.org/10.1016/j.jbo.2022.100454

IF: 4.491

2022-01-01

Journal of Bone Oncology

Abstract:Background: Langerhans cell histiocytosis (LCH) is a rare monoclonal histiocytic neoplasm. Little is known about clinical factors associated with LCH single-vs multi-system involvement at the time of diagnosis.Methods: Data on 1549 LCH patients diagnosed between years 2010 and 2018 were extracted from the Sur-veillance, Epidemiology and End Results Program. Patterns of single-vs multisystem involvement were examined using multivariable logistic regression analysis. Odd ratio (OR) and 95% confidence interval (CI) were reported. Results: 968 children and adolescents (0-19 years; median: 4 years) and 581 adults (>= 20 years; median: 49 years) were included in the analysis. Multi-system LCH was reported for 30.9 % patients. Bone marrow (BM) (OR = 3.776; 95 %CI = 1.939-7.351; P < 0.001) and lymph node (LN) (OR = 3.274; 95 %CI = 1.443-7.427; P = 0.005) involvement were most commonly associated with multi-system LCH at the time of diagnosis; similar pattern was also observed in adult patients (OR = 17.780; 95 %CI = 6.469-48.867; P < 0.001 for BM LCH; and OR = 5.156;95 %CI = 2.131-12.471; P < 0.001 for LN LCH). Among pediatric patients, craniofacial osseous LCH was more likely to be treated with surgery (OR = 2.822; 95 %CI = 1.199-6.639; P = 0.018) compared to skeletal lesions in other sites, whereas vertebral body LCH was less likely to be treated with surgery (OR = 0.175; 95 %CI = 0.058-0.527; P = 0.002). In pediatric patients with bone LCH, the non-white patients were less likely to be treated surgically compared to the white patients (OR = 0.470; 95 %CI = 0.272-0.812; P = 0.007).Conclusions: BM and LN LCH are associated with the highest risks of multi-system disease, which may require active surveillance. Furthermore, active attempts are needed to mitigate the racial disparity in surgery utilization in pediatric patients with skeletal LCH.
A Case Of An Adult Langerhans Cell Sarcoma

Xiaolei Ma,Wenhai Li,Juan Du,Lin Cai,Jianzhong Zhang

DOI: https://doi.org/10.1111/ijd.12440

2016-01-01

International Journal of Dermatology

Abstract:International Journal of DermatologyVolume 55, Issue 1 p. 92-96 Case Report A case of an adult Langerhans cell sarcoma Xiaolei Ma MD, Xiaolei Ma MD Department of Dermatology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorWenhai Li MD, Wenhai Li MD Department of Dermatology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorJuan Du MD, Juan Du MD Department of Dermatology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorLin Cai MD, Lin Cai MD Department of Dermatology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorJianzhong Zhang MD, Corresponding Author Jianzhong Zhang MD Department of Dermatology, Peking University People's Hospital, Beijing, China Correspondence Jianzhong Zhang, md Department of Dermatology Peking University People's Hospital South Street 11#, Xi Zhi Men, Xi Cheng distrist Beijing China E-mail: [email protected]Search for more papers by this author Xiaolei Ma MD, Xiaolei Ma MD Department of Dermatology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorWenhai Li MD, Wenhai Li MD Department of Dermatology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorJuan Du MD, Juan Du MD Department of Dermatology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorLin Cai MD, Lin Cai MD Department of Dermatology, Peking University People's Hospital, Beijing, ChinaSearch for more papers by this authorJianzhong Zhang MD, Corresponding Author Jianzhong Zhang MD Department of Dermatology, Peking University People's Hospital, Beijing, China Correspondence Jianzhong Zhang, md Department of Dermatology Peking University People's Hospital South Street 11#, Xi Zhi Men, Xi Cheng distrist Beijing China E-mail: [email protected]Search for more papers by this author First published: 14 October 2014 https://doi.org/10.1111/ijd.12440Citations: 1 Conflicts of interest: None. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume55, Issue1January 2016Pages 92-96 RelatedInformation
Multi-system Langerhans cell histiocytosis in children：a clinicopathologic study of 8 cases

Manli ZHAO,Kun ZHU,Min YANG,Weizhong GU,Yun ZHAO,Yan SHU,Hongfeng TANG

DOI: https://doi.org/10.3978/j.issn.2095-6959.2015.06.031

2015-01-01

Abstract:Objective:To study clinical and histopathological characteristics, diagnostic criteria, differential diagnosis and prognosis of systematic Langerhans cell histiocytosis in children.Methods: Clinical and pathological features were studied in 8 cases of multi-system Langerhans cell histiocytosis with review of the literatures.Results:hTere were 1 males and 7 females. hTe youngest was 13-day-old and the oldest was 3 years and 5 months old. Among those MS-LCH patients, 6 patients had risk organ involvement. The clinical symptoms included fever, skin eruption or anemia, with inifltrative lesion of liver, spleen, lymph node, bone and hematopoietic system. Microscopically, the disease was characterized by clonal hyperplasia of histiocytes with folded nucleus. Immunohistochemical staining showed that the histiocytes were positive for CD1a and S-100.Conclusion: Multi-system Langerhans cell histiocytosis presents complex clinical symptoms. hTe diagnosis needs a combination of clinical features, image examination and histopathological characters. If the risk organ was involved, the prognosis is poor.
Uncommon Cutaneous Non-Langerhans Cell Histiocytosis Arising from Dermal Dendritic Cells in Adults: a Clinicopathological Study of Five Cases.

Lin Nong,Yali Ren,Ying Dong,Dong Li,Xin Li,Ting Li

DOI: https://doi.org/10.1684/ejd.2019.3679

2020-01-01

European Journal of Dermatology

Abstract:Background Non-Langerhans cell histiocytosis (non-LCH) is a collective term that encompasses a long list of rare "histiocytosis" that do not meet the criteria for Langerhans cell histiocytosis (LCH). Among cutaneous non-LCH, the xanthogranuloma (XG) family represents a distinct group of disorders derived from dermal dendritic cells (DDCs) at different stages of differentiation. Objective To investigate the clinicopathological characteristics of the XG family in adults and review the relevant literature. Materials and Methods We performed a retrospective clinicopathological study of five adult cases with a previous diagnosis of non-LCH. Clinicopathological features, immunophenotypes, genetic alterations and ultrastructural characteristics were analysed. Results Skin biopsies revealed that all five cases were characterized by diffuse infiltration of polymorphic cells, which were immunoreactive to factor XIIIa but negative for Langerin, CD1a, and S100. None of the cases harboured the BRAF V600E mutation. Electron microscopy of two cases exhibited abundant cytoplasmic processes with numerous lysosome-like dense bodies and electron-lucent vesicles in the cytoplasm and extracellular matrix. The overall features suggested that DDCs are the cellular origin, and these cases fulfilled the criteria for the XG family. Conclusion The XG family represents a spectrum of rare diseases with different clinical presentations, a wide range of morphological appearances, and a shared common origin (DDCs). This group of disorders has been proposed as a unique entity with diagnostic challenges that should not be underestimated.
Multisystemic Recurrent Langerhans Cell Histiocytosis Misdiagnosed with Chronic Inflammation at the First Diagnosis: A Case Report

Zhan-Rong Zhang,Feng Chen,Hui-Juan Chen

DOI: https://doi.org/10.4329/wjr.v16.i6.232

2024-01-01

World Journal of Radiology

Abstract:BACKGROUND Langerhans cell histiocytosis (LCH) is characterized by diabetes insipidus and is an uncommon occurrence. Pathological biopsies still have a certain degree of diagnostic probability. We present a case in which LCH initially affected the pituitary gland. This resulted in a misdiagnosis of chronic inflammation upon pathological examination. CASE SUMMARY A 25-year-old female exhibited symptoms of diabetes insipidus. Magnetic resonance imaging revealed an enhanced foci in the pituitary gland. After surgical resection of the pituitary lesion, the pathological diagnosis was chronic inflammation. However, the patient later experienced bone destruction in the skull and lower limb bones. After the lower limb bone lesion was compared with the initial pituitary lesion, the final diagnosis was modified to LCH. The patient was treated with multiple chemotherapy courses. However, the patient’s condition gradually worsened, and she eventually passed away at home. CONCLUSION LCH should be considered when patients exhibit diabetes insipidus and absence of high signal intensity in the pituitary gland on sagittal T1-weighted image and abnormal enhancement in the pituitary region.
A Case Report Of Disseminated Histiocytic Sarcoma

Zhengxiao Zhao,Xiaolong Zhao,Yingfeng Zhu,Weiyi Gong,Kai Wei,Zhiyuan Bo,Jingcheng Dong

2017-01-01

Abstract:Background: Histiocytic sarcoma (HS) is an extremely rare and aggressive malignant neoplasm. Most of the HS cases reported before are now considered to be T-lineage-associated hematolymphoid neoplasms. This report describes a case of pathological verified HS. Main observations: A 59-year-old Chinese man presented to the clinic with complains of weight loss and hypodynamia. Histopathological examination revealed a predominant population of large non-cohesive cells with bizarre pleomorphic shape, lobulated nuclei and abundant foamy cytoplasm. Immunohistochemistry was positive for KP-1 (CD68), CD14, lysozyme, Vim, LCA and S100, but negative for CD1a, CD21, CD35, CD3, CD56, CD30, EMA, ALK, SOX-100 and HMB45. The clinical presentation of enlarged lymph nodes and malignant mass within retroperitoneum, as well as the H&E and a panel of immunohistochemical staining made the diagnosis of histiocytic sarcoma. Conclusion: We describe a case report of HS which is verified by immunohistochemical examination and discuss the clinical and pathological presentations, diagnosis, therapy and genetic alterations underlying this uncommon neoplasm. Invasive progression and lack of effective treatment methods of HS deprive the survival chance of this patient. Early diagnosis methods and novel therapies are urgent be developed.
Langerhans Cell Histiocytosis in Adolescent Patients: a Single-Centre Retrospective Study

Cai Hua-cong,Chen Jia,Liu Ting,Cai Hao,Duan Ming-hui,Li Jian,Zhou Dao-bin,Cao Xin-xin

DOI: https://doi.org/10.1186/s13023-022-02436-0

2022-01-01

Orphanet Journal of Rare Diseases

Abstract:Background Langerhans cell histiocytosis (LCH) is a myeloid dendritic cell disorder frequently affecting children more than adults. The presentation of LCH varies with age, however, the clinical characteristics and genetic profiles of adolescent LCH remain elusive. To address the knowledge gap, we performed a single-centre retrospective study of 36 adolescent LCH patients aged between 14 and 17 years at Peking Union Medical College Hospital. Results At the time of diagnosis, 10 patients were classified as unifocal single system LCH (27.8%), 2 patients had pulmonary single system LCH (5.6%), 5 patients had multifocal single system LCH with bone involvement (13.9%), and 19 patients had multisystem LCH (52.8%). The most prevalent involvement in multisystem patients was the pituitary gland (78.9%), followed by the bone (42.1%), lung (42.1%), and lymph nodes (42.1%). Eight (42.1%) patients had risk organ involvement. BRAF N486_P490 was detected in 50% of patients who underwent next generation sequencing, and BRAF V600E was detected in one patient. Chemotherapies were the first line treatment in 24 patients. One patient died and thirteen patients relapsed during the follow-up. The estimated 5-year OS rate and EFS rate were 94.7% and 59.0%, respectively. Conclusions In this study, we report a large series of adolescent LCH patients. The clinical characteristics of adolescent LCH patients may be close to adult LCH. Compared with pediatric cases, adolescent LCH tends to have more pituitary lesions and pulmonary involvement, fewer skin and hematopoietic involvement, a higher frequency of BRAF deletion mutation, and a lower frequency of BRAF V600E mutation.
Multisystem Langerhans Cell Histiocytosis following Treatment of Initially Presumed Atopic Dermatitis with Dupilumab: A Case Report of an Extremely Confusing Scenario

Wenhao Cheng,Hong Ren,Wenlong Hu

DOI: https://doi.org/10.1159/000539704

2024-07-01

Abstract:Introduction: Atopic dermatitis (AD) is a common chronic, recurrent, and non-infectious inflammatory skin disease. Dupilumab is a human monoclonal antibody with clinical efficacy in severe AD and has a good safety profile. Case presentation: We hereby describe a previously unreported case of multisystem Langerhans cell histiocytosis (MS-LCH) that is associated with a history of AD treatment using dupilumab. Conclusion: A single case of MS-LCH with a history of dupilumab treatment for AD was described for the first time. This case highlights that given its susceptibility to skin involvement, LCH needs to be considered as a differential diagnosis for skin lesions that are not improved by established therapies.

Single-system Langerhans Cell Histiocytosis with Skin Ulcers as the Initial Presentation

Small Cell Lung Cancer Presenting As Dermatomyositis: Mistaken for Single Connective Tissue Disease

Huriez Syndrome with Squamous Cell Carcinoma

Skin Picking in Atopic Dermatitis and Psoriasis Patients: A Single-centre Cross-sectional Study in China

Cutaneous Langerhans Cell Histiocytosis in an Old Man:A Case Report

A rare imaging presentation with multisystemic clinicopathological features of Langerhans cell histiocytosis: Case report and literature review

Adult Presentation of Cutaneous Langerhans Cell Histiocytosis

A case report of multicentric reticulohistiocytosis with atypical cutaneous presentation

Clinical characteristics, genomic profiling and outcomes of single system multifocal Langerhans cell histiocytosis in adults with bone involvement

Primary cutaneous aggressive epidermotropie CD8-positive cytotoxic T-cell lymphoma:a case report

Single-cell analyses reveal novel molecular signatures and pathogenesis in cutaneous T cell lymphoma

Chronic lymphocytic leukemia/small lymphocytic lymphoma complicated with skin Langerhans cell sarcoma: A case report

Adult Langerhans cell histiocytosis with multi‑system bone, skin, lung and liver involvement: A case report

Langerhans Cell Histiocytosis: A Population-based Study of Anatomical Distribution and Treatment Patterns

A Case Of An Adult Langerhans Cell Sarcoma

Multi-system Langerhans cell histiocytosis in children：a clinicopathologic study of 8 cases

Uncommon Cutaneous Non-Langerhans Cell Histiocytosis Arising from Dermal Dendritic Cells in Adults: a Clinicopathological Study of Five Cases.

Multisystemic Recurrent Langerhans Cell Histiocytosis Misdiagnosed with Chronic Inflammation at the First Diagnosis: A Case Report

A Case Report Of Disseminated Histiocytic Sarcoma

Langerhans Cell Histiocytosis in Adolescent Patients: a Single-Centre Retrospective Study

Multisystem Langerhans Cell Histiocytosis following Treatment of Initially Presumed Atopic Dermatitis with Dupilumab: A Case Report of an Extremely Confusing Scenario